Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.

NCT06701032 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT06701032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06701032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 25, 2024
Completion date
September 30, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular atherosclerosis, coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd)), peripheral artery disease (pad)